MiMedx Group, Inc (MDXG) by event type
MDXG moves most on analyst downgrades — a median of -0.74% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the MDXG overview →
How MDXG reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,297 of 2,717 | 10 | -0.41% | 40% | +0.54% |
| Analyst downgrades 2,342 of 2,603 | 10 | -0.74% | 20% | -0.63% |
| Coverage initiations 1,784 of 2,283 | 13 | -0.32% | 8% | -0.43% |
| Rating reiterations 3,181 of 3,522 | 26 | -0.34% | 46% | +0.11% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how MDXG usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · MDXG overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cellectar Biosciences, Inc. (CLRB) | 265 | +0.27% | 52% |
| EVOTEC AG S/ADR (EVTCY) | 265 | 0.00% | 17% |
| Relmada Therapeutics, Inc. (RLMD) | 265 | -0.01% | 44% |
| HUTCHMED (China) Limited - American Depositary Shares (HCM) | 263 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.